Gastric Cancer Adenocarcinoma Metastatic Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer
Gastric Cancer Adenocarcinoma Metastatic
Dai, Guanghai68 enrolled1 locationNCT07392346
Recruiting
Phase 2
Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer
Gastric Cancer Adenocarcinoma Metastatic
LIN YANG31 enrolled1 locationNCT06711471